Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News

European Patient Access to New Drugs Worsens

Patient access to new medicines is worsening across Europe, the region's main pharmaceuticals industry ⁠lobby group said.

Wrist Air Samplers Detect Virus Exposure in Kids With Asthma

Devices may inform disease prevention strategies by providing community-level data.

Colistin MIC Affects Outcomes in Gram-Negative Infections

In carbapenem-resistant gram-negative infections caused by pathogens for which the colistin MIC is 2 mg/L, the colistin-meropenem combination is linked to better clinical outcomes than colistin alone.

What 300,000 Implants Say About Light Adjustable Lens

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Parkinson’s Disease Deaths Decline Among Older US Adults

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka Battles Surge in Dengue Fever, With More Than 44,000 Cases So Far This Year

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

Patient access to new medicines is worsening across Europe, the region's main pharmaceuticals industry ⁠lobby group said.

Devices may inform disease prevention strategies by providing community-level data.

In carbapenem-resistant gram-negative infections caused by pathogens for which the colistin MIC is 2 mg/L, the colistin-meropenem combination is linked to better clinical outcomes than colistin alone.

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

News All Time

Infections Tied to Asthma Attacks on Benralizumab Therapy

In patients with eosinophilic asthma on benralizumab, attacks often feature airway neutrophilia, respiratory viruses, and microbiome shifts, indicating infections are a key cause of exacerbations.

EMA Holds Valproate Precautions Despite Mixed Evidence

EMA has found inconsistent data on developmental disorders in children of fathers using valproate before conception and retains existing precautions.

Housing Instability Can Threaten Diabetic Retinopathy Care

Analysis of electronic health record data shows unhoused patients with diabetes have more severe diabetic retinopathy and higher rates of vision-threatening complications than stably housed patients.

Congo's Ebola Outbreak Spreads to New Health Zones

Congo's Ebola outbreak has spread ⁠to three new health zones, according to ⁠a government report published on Thursday that ⁠showed the ‌number of confirmed cases had risen...

India Raises Price Cap on Cancer Drugs to Tackle Shortage

India's drug price regulator raised ceiling rates for two key platinum-based cancer drugs by 50% after a surge ⁠in raw material costs triggered widespread shortages,...

Good Outcomes with Ublituximab in First Real-World Study

Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Congo’s Ebola Outbreak Spreads to New Health Zone

Congo's Ebola outbreak has spread to a new health zone in the northeastern ⁠province of Ituri, authorities said on Wednesday, as fresh infections underline sustained...

Valencia Floods Highlight Missing Hospital Protocols

A cold snap that hit hundreds of thousands showed how quickly hospitals can lose order, with radiology calling for empathy, leadership, and real disaster protocols.

High-Dose Flu Shot Beats Standard Dose in Older Adults

High-dose influenza vaccine offers better protection than standard-dose influenza vaccine against several serious hospitalization outcomes in adults aged 65 years or older, a meta-analysis finds.

Why Are Ketogenic Diets Effective for Epilepsy?

A century-old dietary therapy remains one of neurology’s most effective treatments for drug-resistant epilepsy — and one of its least understood.

Berlin Hospital Discharges US Doctor Who Contracted Ebola

A U.S. citizen treated in Germany ⁠after contracting Ebola in the Democratic Republic of Congo has been discharged, ⁠a Berlin hospital said on Saturday.

Antibiotic Resistance Genes Found Across World Oceans, Italian Study Shows

Genes linked to antibiotic resistance are present across multiple ocean basins, including remote waters, according to findings ⁠released on Monday from an Italian-led...

Getting a Syphilis Test May Signal Higher Stroke Risk

Individuals who undergo syphilis testing, regardless of the result, face a substantially higher risk for stroke than individuals from the general population, a study shows.

Baricitinib May Offer Short-Term Benefits in Early Arthritis

In patients with undifferentiated arthritis, early treatment with baricitinib is linked to a greater 3-month improvement in disease activity than symptomatic treatment with NSAIDs.

Scope of Practice in Eye Care: Pendulum Swinging Too Far?

A shortage of eye specialists has led states to consider allowing nonphysicians to perform in-office surgical procedures. Medscape wants to know: What do you think of these proposed expansions of practice?

Low Outdoor Exposure in Winter Linked to Paediatric MS Risk

Reduced outdoor exposure during winter in early childhood is linked to higher odds of developing paediatric multiple sclerosis across early-life age groups.

Recommended News For You

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

Inside the Major Findings From the NHS-Galleri Trial

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

Lower screening age calls for more tailored bowel cancer surveillance

Recommended Articles For You

Integrative Cancer Care: Nutrition, Social Work, Care Coordination, and Genetic Counseling 

Multiple Myeloma: Understanding the Basics  

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

2.

Hybrid imaging test combines antibody and radioisotope for early lung cancer detection

3.

Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors

4.

Simpler Screening Criteria Could Catch More Lung Cancers

5.

Oncologist Sued for Double-Billing; Pharmacy Deserts; 'She Loved Scotch and Pizza'

1.

An Overview Of Serum Osmolality: What Is It And How Can It Help You?

2.

Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology

3.

Essential Oncology Tools: Risk Assessment, Telehealth, AI, and Monitoring

4.

Exploring the Unknown: Unveiling the Mysteries of GIST Tumors

5.

Fibroma: Understanding the Causes, Symptoms, and Treatment Options

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

3.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

4.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot